United States · Bill · S
S. 551 (116th)
REFUND Act of 2019
Introduced
25 February 2019
Last action
—
Status
Read twice and referred to the Committee on Finance. (text: CR S1439)
Sponsors
—
Subjects
Discovery layer
Source updated
3 December 2025
Summary
Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 or the REFUND Act of 2019 This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) in relation to discarded amounts (i.e., amounts remaining after administration) of single-dose vial drugs that are covered under Medicare. Manufacturers that fail to comply are subject to civil penalties. The CMS must determine rebate amounts based on payment claims from providers. (Currently, providers may receive payment under Medicare for discarded amounts of single-dose vial drugs through the use of a specific claims modifier.)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 25 February 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 25 February 2019
Introduced in Senate
summary · EN · 25 February 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/551
- Open data entity: https://api.congress.gov/v3/bill/116/s/551